Research Paper Volume 4, Issue 11 pp 755—767

Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease


Figure 4. The effect of MIA-690 on the survival of the 5XFAD transgenic mice over 6 months. Numbers on each line represent the estimated mean survival time for each group. Mice were treated with daily subcutaneous injections of GHRH antagonist MIA-690 at doses of 2, 5, and 10 μg for 6 months.